99% Molnupiravir Powder Treatment FIPV Molnunat 200mg Tablet 25kg/Drum

EIDD-2801, also known as Molnupiravir, is an antiviral drug developed for the treatment of viral infections, particularly those caused by RNA viruses.

The primary mechanism of action involves inhibiting viral replication by inducing lethal mutations in the genetic material of the virus. Once metabolized into its active form, EIDD-2801 mimics RNA building blocks, introducing errors into viral RNA sequences during replication. This results in nonviable or less infectious viral progeny, effectively disrupting viral spread.

EIDD-2801 demonstrates broad-spectrum activity against various RNA viruses including influenza viruses, coronaviruses (such as SARS-CoV-2), and respiratory syncytial virus (RSV), making it a promising candidate for treating multiple viral infections.

EIDD-2801 is particularly valuable for rapid response to emerging viral threats and pandemic situations. Its broad-spectrum antiviral activity and replication inhibition capabilities make it a versatile agent for managing infectious diseases.

• 1~25kgs packaging: Aluminium bag inside, Carton box outside
• 25kgs packaging: Plastic bag inside, Fiber drum outside